Supplementary Table S2 from Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 2.ctDNA Data for 29 and cfRNA Data for 26 Patients in Dose
创建时间：
2024-03-15
